pharmaphorum

DECEMBER 29, 2022

The case revolves around allegations that Novartis made an agreement in 2011 with Par Pharmaceutical when Exforge (valsartan/amlodipine) was nearing the end of its patent life that was designed to keep Par’s generic version of the drug off the market until 30 September, 2014.

Specialty Pharmacies 52

Specialty Pharmacies Documentation 52

Ramblings of a pharmacist

FEBRUARY 16, 2022

I presume that their fill-at-specialty-pickup-at-retail program counts these rx revenues in the specialty pharmacy division. rx - they don't appear to report their specialty pharmacies as a separate division. Compare Walgreens as well , page 45 of their 10-k shows $107701M/818M rxs = $131.66/rx

Independent Pharmacies 52

Independent Pharmacies Compounding Specialty Pharmacies Prescription Filling 52

Pharma Marketing Network

JUNE 10, 2020

At the moment, it started off with, you know, five 8 10 million in 2011. And the number of deals that are going up, sort of number of deals that are being done are also going up from a high of 300 in 2011, to about 800 deals in 2018. And it’s gone up to about 30 million. So we’ve seen the deals are becoming larger.

Hospitals 52

Hospitals Specialty Pharmacies Medical Records Packaging 52

Pharma Marketing Network

JUNE 10, 2020

At the moment, it started off with, you know, five 8 10 million in 2011. And the number of deals that are going up, sort of number of deals that are being done are also going up from a high of 300 in 2011, to about 800 deals in 2018. And it’s gone up to about 30 million. So we’ve seen the deals are becoming larger.

Hospitals 40

Hospitals Specialty Pharmacies Medical Records Packaging 40